AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

Research

Advancing Pediatric, Maternal and Child Health

Future Directions for NIAID HIV Research

Co-authored by Edward Handelsman, M.D., Chief of NIAID’s Pediatric Medicine Branch within the Division of AIDS, and Lynne Mofenson, M.D., Chief of the Pediatric, Adolescent and Maternal AIDS Branch within the Eunice Kennedy Shriver National Institute of Child Health & Human Development. As a result of our continued dialogue with our collaborators and stakeholders, NIAID…

NIAID to Host Public Meeting on Future HIV/AIDS Research Networks

blog.aids.gov

The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH will host a public meeting on Tuesday, October 26, 2010, in Arlington, Va., to examine the future of the Institute’s HIV/AIDS clinical trial networks. Currently, NIAID supports six HIV/AIDS networks; the awards supporting those networks are set to expire in 2013 and…

Future Directions for NIAID HIV Research: Consider and Comment

blog.aids.gov

The National Institute of Allergy and Infectious Diseases (NIAID) is developing a series of blog posts here on AIDS.gov related to planning for the future of NIAID’s HIV/AIDS clinical trial networks. Each blog post focuses on specific aspects of the network restructuring in which NIAID is seeking input from the broader research and HIV/AIDS communities….

Interview with Ernest Hopkins and Bob Grant about Pre-exposure Prophylaxis (PrEP)

blog.aids.gov

Recently I sat down with Ernest Hopkins, Legislative Director at the San Francisco AIDS Foundation , and Bob Grant, M.D.,M.P.H. , Senior Investigator at the Gladstone Institute at University of California San Francisco , to talk about pre-exposure prophylaxis (PrEP). Here is a video from our conversation.

International AIDS Conference 2010: Highlights & Key Scientific Outcomes From Andrew Fullem

Andrew Fullem, MSPH

I’ve been fortunate to attend international HIV conferences for many years. Several of those conferences stand out in my memory for the results they produced. In Vancouver (1996), researchers first announced the results of the highly active antiretroviral therapy (HAART) clinical trials—changing the future for millions of us living with HIV. In Durban (2000), delegates…

NIH-Led Scientists Find Antibodies that Prevent Most HIV Strains from Infecting Human Cells

blog.aids.gov

Scientists have discovered two potent human antibodies that can stop more than 90 percent of known global HIV strains from infecting human cells in the laboratory. The scientists also have demonstrated how one of these disease-fighting proteins accomplishes this feat. According to the scientists, these antibodies could be used to design improved HIV vaccines, or…

Wrap-up from the International AIDS Conference in Vienna

IAC 2010 attendees

Co-authored by Michelle Samplin-Salgado, AIDS.gov New Media Strategist Today is the last day of the International AIDS Conference . Throughout the week we’ve had the pleasure of hearing key scientific outcomes along with policy and program updates from the meeting. We were encouraged by the expanded use of new media at the conference this year….

Bringing the International AIDS Conference to DC in 2012

blog.aids.gov

I have had the pleasure of participating in the 18th International AIDS Conference in Vienna this past week. As you may know, last week, President Obama held a reception at the White House to celebrate the work of the HIV/AIDS community as his Administration launched the first comprehensive National HIV/AIDS Strategy. The positive reaction to…